Novartis AG Overview

Novartis AG Selling, General & Admin

Selling, General & Admin expenses for NVS.

Quarterly SG&A Expenses

$3.08B

↑ 0.65% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$13.29B

↑ 3.25% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin